<?xml version="1.0" encoding="UTF-8"?>
<fig id="Fig1">
 <label>Fig. 1</label>
 <caption>
  <p>Effects of olaparib on influenza virus challenge-induced mortality in mice. (a) Chemical structure of olaparib. (b) Mice from each experimental group were treated for 2 days before viral challenge and 6 days after infection and survival for 15 consecutive days. Oseltamivir was used as positive control. Ola, olaparib group; IAV, influenza A virus-infected group. 
   <italic>n</italic> = 20 in each group. 
   <sup>*</sup>
   <italic>p</italic> &lt; 0.05, 
   <sup>**</sup>
   <italic>p</italic> &lt; 0.01, and 
   <sup>***</sup>
   <italic>p</italic> &lt; 0.001 compared with the IAV infection group
  </p>
 </caption>
 <graphic xlink:href="10096_2020_4020_Fig1_HTML" id="MO1" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
